EXL · 1 day ago
Auditor III - DRG
Maximize your interview chances
AnalyticsBanking
Insider Connection @EXL
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Conduct MS-DRG and/or APR-DRG coding reviews to verify the accuracy of the DRG assignment and reimbursement.
Apply coding guidelines to a variety of claim scenarios and effectively utilize industry and proprietary tools to maximize overpayment identifications.
Document audit results in a clear, concise, and effective manner using AHA Coding Clinic Guidelines and ICD 10 CM/PCS coding rules and guidelines.
Utilize proprietary workflow systems and encoder tools (e.g., 3M, Webstrat, etc.) efficiently and accurately to make audit determinations, generate audit rationales and move claims through workflow process correctly.
Meet or exceed EXL established program productivity and quality goals, including uphold rate for appeals.
Demonstrate knowledge of and compliance with changes and updates to coding guidelines, reimbursement trends, and client processes and requirements.
Comply with all EXL policies and procedures including HIPAA and other state and federal regulations.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Minimum High School Diploma
One or more of the following credentials: CCS, RHIA, RHIT; preference given to those with multiple credentials
4+ years of MS DRG/APR DRG coding experience with expert knowledge of AHA Coding Guidelines, DRG reimbursement methodologies, and familiarity with health care payer contract language.
Preferred
Prefer candidate with prior DRG retrospective overpayment identification auditing experience.
Company
EXL
EXL is a provider of Transformation and Outsourcing services to Global 1000 companies in multiple industries
Funding
Current Stage
Public CompanyTotal Funding
$150MKey Investors
The Orogen GroupFTV Capital
2018-10-02Post Ipo Debt· $150M
2006-10-20IPO· undefined
2004-12-01Series Unknown· undefined
Leadership Team
Recent News
2024-06-04
Company data provided by crunchbase